Dysfunction of stress responsive systems as a risk factor for functional somatic syndromes

Journal of Psychosomatic Research

Volumn 68, Issue 5, 2010, Pages 461-468

  Tak, Lineke M ^a   Rosmalen, Judith G M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Autonomic nervous system; Functional somatic symptoms; Functional somatic syndromes; Hypothalamus pituitary adrenal axis; Somatoform; Stress

Indexed keywords

BIOLOGICAL FACTOR;

AUTONOMIC NERVOUS SYSTEM; FUNCTIONAL SOMATIC SYNDROME; HEART VALVE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MEDICAL RESEARCH; MENTAL STRESS; PSYCHOSOMATIC DISORDER; REVIEW; RISK FACTOR; SOCIAL ASPECT; SOCIAL PSYCHOLOGY; STRESS;

HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; PSYCHOPHYSIOLOGIC DISORDERS; RISK FACTORS; SOMATOFORM DISORDERS; STRESS, PSYCHOLOGICAL;

EID: 77953752241     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2009.12.004     Document Type: Review

References (68)

1. Deary V, Chalder T, Sharpe M The cognitive behavioural model of medically unexplained symptoms: a theoretical and empirical review. Clin Psychol Rev 2007, 27:781-797.
2. Van Houdenhove B, Egle U, Luyten P The role of life stress in fibromyalgia. Curr Rheumatol Rep 2005, 7:365-370.
3. Mayer EA, Naliboff BD, Chang L, Coutinho SV. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2001, 280:G519-G524.
4. McEwen BS Protective and damaging effects of stress mediators. N Engl J Med 1998, 338:171-179.
5. Genuth SM The hypothalamus and pituitary gland. Physiology 1998, 872-909. Mosby, Missouri. 4th ed. R.M. Berne, R.L. Levy (Eds.).
6. Willis WD The autonomic nervous system and its central control. Physiology 1998, 233-248. Mosby, Missouri. 4th ed. R.M. Berne, R.L. Levy (Eds.).
7. Miller GE, Chen E, Zhou ES If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychol Bull 2007, 133:25-45.
8. Dishman RK, Nakamura Y, Garcia ME, Thompson RW, Dunn AL, Blair SN Heart rate variability, trait anxiety, and perceived stress among physically fit men and women. Int J Psychophysiol 2000, 37:121-133.
9. Lucini D, Di FG, Parati G, Pagani M Impact of chronic psychosocial stress on autonomic cardiovascular regulation in otherwise healthy subjects. Hypertension 2005, 46:1201-1206.
10. Cleare AJ The neuroendocrinology of chronic fatigue syndrome. Endocr Rev 2003, 24:236-252.
11. Tak LM, Rosmalen JGM Psychoneuroendocrinology of functional somatic disorders. Psychoneuroendocrinology research trends 2007, 463-495. Nova Science Publishers, Inc., Hauppage, NY. M.T. Czberska (Ed.).
12. Heim C, Ehlert U, Hellhammer DH The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000, 25:1-35.
13. Rief W, Barsky AJ Psychobiological perspectives on somatoform disorders. Psychoneuroendocrinology 2005, 30:996-1002.
14. Sharpe M, Bass C Pathophysiological mechanisms in somatization. Int Rev Psychiatry 1992, 4:81-97.
15. Kraemer HC, Kazdin AE, Offord DR, Kessler RC, Jensen PS, Kupfer DJ Coming to terms with the terms of risk. Arch Gen Psychiatry 1997, 54:337-343.
16. Tak LM, Riese H, De Bock GH, Manoharan A, Kok IC, Rosmalen JG As good as it gets? A meta-analysis and systematic review of methodological quality of heart rate variability studies in functional somatic disorders. Biol Psychol 2009, 82:101-110.
17. Boneva RS, Decker MJ, Maloney EM, Lin JM, Jones JF, Helgason HG, et al. Higher heart rate and reduced heart rate variability persist during sleep in chronic fatigue syndrome: a population-based study. Auton Neurosci 2007, 137:94-101.
18. Tak LM, Janssens KA, Dietrich A, Slaets JP, Rosmalen JG Age-specific associations between cardiac vagal activity and functional somatic symptoms: a population-based study. Psychother Psychosom 2009, (in press).
19. Jindal RD, Vasko RC, Jennings JR, Fasiczka AL, Thase ME, Reynolds CF Heart rate variability in depressed elderly. Am J Geriatr Psychiatry 2008, 16:861-866.
20. Sandercock GR, Bromley PD, Brodie DA The reliability of short-term measurements of heart rate variability. Int J Cardiol 2005, 103:238-247.
21. Houtveen JH, Rietveld S, de Geus EJ Exaggerated perception of normal physiological responses to stress and hypercapnia in young women with numerous functional somatic symptoms. J Psychosom Res 2003, 55:481-490.
22. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996, 93:1043-1065.
23. Rechlin T The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability. J Clin Psychopharmacol 1994, 14:392-395.
24. Nolan RP, Kamath MV, Floras JS, Stanley J, Pang C, Picton P, et al. Heart rate variability biofeedback as a behavioral neurocardiac intervention to enhance vagal heart rate control. Am Heart J 2005, 149:1137.
25. Tang YY, Ma Y, Fan Y, Feng H, Wang J, Feng S, et al. Central and autonomic nervous system interaction is altered by short-term meditation. Proc Natl Acad Sci U S A 2009, 106:8865-8870.
26. Sandercock GR, Bromley PD, Brodie DA Effects of exercise on heart rate variability: inferences from meta-analysis. Med Sci Sports Exerc 2005, 37:433-439.
27. Sloan RP, Shapiro PA, DeMeersman RE, Bagiella E, Brondolo EN, McKinley PS, et al. The effect of aerobic training and cardiac autonomic regulation in young adults. Am J Public Health 2009, 99:921-928.
28. Rosmalen JGM, Tak LM, Ormel J, Wessely S, Kok I, Cleare A, Manorahan A. Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders. American Psychosomatic Society Annual Meeting, March 10-13, 2010, Abstract 1234.
29. Tak LM, Cleare AJ, Ormel J, Manoharan A, Kok IC, Wessely S, Rosmalen JG. Meta-analysis and meta-regression of HPA axis activity in functional somatic disorders. Abstract 68th Annual Scientific Meeting of the American Psychosomatic Society, Portland, 2010.
30. Fabian LA, McGuire L, Page GG, Goodin BR, Edwards RR, Haythornthwaite J The association of the cortisol awakening response with experimental pain ratings. Psychoneuroendocrinology 2009, 34:1247-1251.
31. Dahlgren A, Kecklund G, Theorell T, Akerstedt T Day-to-day variation in saliva cortisol-Relation with sleep, stress and self-rated health. Biol Psychol 2009, 82:149-155.
32. Tak LM, Rosmalen JGM, Bakker SJL. Dysfunction of the hypothalamic-pituitary-adrenal-axis and functional somatic symptoms: a longitudinal cohort study in the general population. Psychoneuroendocrinology 2009, 34:869-877.
33. Cleare AJ The HPA axis and the genesis of chronic fatigue syndrome. Trends Endocrinol Metab 2004, 15:55-59.
34. Tanriverdi F, Karaca Z, Unluhizarci K, Kelestimur F The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome. Stress 2007, 10:13-25.
35. Bouma EM, Riese H, Ormel J, Verhulst FC, Oldehinkel AJ. Adolescents' cortisol responses to awakening and social stress; effects of gender, menstrual phase and oral contraceptives. The TRAILS study. Psychoneuroendocrinology 2009, 34:884-893.
36. Wust S, Federenko I, Hellhammer DH, Kirschbaum C Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology 2000, 25:707-720.
37. Lariviere WR, Melzack R The role of corticotropin-releasing factor in pain and analgesia. Pain 2000, 84:1-12.
38. Clauw DJ, Chrousos GP Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 1997, 4:134-153.
39. Fries E, Hesse J, Hellhammer J, Hellhammer DH A new view on hypocortisolism. Psychoneuroendocrinology 2005, 30:1010-1016.
40. Adam EK, Hawkley LC, Kudielka BM, Cacioppo JT Day-to-day dynamics of experience-cortisol associations in a population-based sample of older adults. Proc Natl Acad Sci U S A 2006, 103:17058-17063.
41. Candy B, Chalder T, Cleare AJ, Peakman A, Skowera A, Wessely S, et al. Predictors of fatigue following the onset of infectious mononucleosis. Psychol Med 2003, 33:847-855.
42. Rubin GJ, Hotopf M, Papadopoulos A, Cleare A Salivary cortisol as a predictor of postoperative fatigue. Psychosom Med 2005, 67:441-447.
43. Kumari M, Badrick E, Chandola T, Adam EK, Stafford M, Marmot MG, et al. Cortisol secretion and fatigue: Associations in a community based cohort. Psychoneuroendocrinology 2009, 34:1476-1485.
44. McBeth J, Silman AJ, Gupta A, Chiu YH, Ray D, Morriss R, et al. Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a population-based prospective cohort study. Arthritis Rheum 2007, 56:360-371.
45. Buijs RM, van Eden CG, Goncharuk VD, Kalsbeek A The biological clock tunes the organs of the body: timing by hormones and the autonomic nervous system. J Endocrinol 2003, 177:17-26.
46. Clow A, Thorn L, Evans P, Hucklebridge F The awakening cortisol response: methodological issues and significance. Stress 2004, 7:29-37.
47. Chida Y, Steptoe A Cortisol awakening response and psychosocial factors: a systematic review and meta-analysis. Biol Psychol 2009, 80:265-278.
48. Ambrogio AG, Pecori GF, Cavagnini F Drugs and HPA axis. Pituitary 2008, 11:219-229.
49. Granger DA, Hibel LC, Fortunato CK, Kapelewski CH. Medication effects on salivary cortisol: Tactics and strategy to minimize impact in behavioral and developmental science. Psychoneuroendocrinology 2009, 34:1437-1448.
50. Abelson JL, Khan S, Liberzon I, Erickson TM, Young EA Effects of perceived control and cognitive coping on endocrine stress responses to pharmacological activation. Biol Psychiatry 2008, 64:701-707.
51. Cleare AJ, Heap E, Malhi GS, Wessely S, O'Keane V, Miell J Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet 1999, 353:455-458.
52. McKenzie R, O'Fallon A, Dale J, Demitrack M, Sharma G, Deloria M, et al. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA 1998, 280:1061-1066.
53. Clark S, Tindall E, Bennett RM A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis. J Rheumatol 1985, 12:980-983.
54. Henningsen P, Zipfel S, Herzog W Management of functional somatic syndromes. Lancet 2007, 369:946-955.
55. Roberts AD, Papadopoulos AS, Wessely S, Chalder T, Cleare AJ Salivary cortisol output before and after cognitive behavioural therapy for chronic fatigue syndrome. J Affect Disord 2009, 115:280-286.
56. Bonifazi M, Suman AL, Cambiaggi C, Felici A, Grasso G, Lodi L, et al. Changes in salivary cortisol and corticosteroid receptor-alpha mRNA expression following a 3-week multidisciplinary treatment program in patients with fibromyalgia. Psychoneuroendocrinology 2006, 31:1076-1086.
57. Roberts AD, Charler ML, Papadopoulos A, Wessely S, Chalder T, Cleare AJ Does hypocortisolism predict a poor response to cognitive behavioural therapy in chronic fatigue syndrome?. Psychol Med 2009, 39:1-8.
58. Prins JB, Bleijenberg G, Bazelmans E, Elving LD, de Boo TM, Severens JL, et al. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet 2001, 357:841-847.
59. Glass JM, Lyden AK, Petzke F, Stein P, Whalen G, Ambrose K, et al. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals. J Psychosom Res 2004, 57:391-398.
60. Craig AD How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci 2002, 3:655-666.
61. Abeles AM, Pillinger MH, Solitar BM, Abeles M Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med 2007, 146:726-734.
62. Lane RD, Waldstein SR, Critchley HD, Derbyshire SW, Drossman DA, Wager TD, et al. The rebirth of neuroscience in psychosomatic medicine, Part II: clinical applications and implications for research. Psychosom Med 2009, 71:135-151.
63. Eriksen HR, Ursin H Subjective health complaints, sensitization, and sustained cognitive activation (stress). J Psychosom Res 2004, 56:445-448.
64. Roelofs K, Spinhoven P Trauma and medically unexplained symptoms towards an integration of cognitive and neuro-biological accounts. Clin Psychol Rev 2007, 27:798-820.
65. Christenfeld NJ, Sloan RP, Carroll D, Greenland S Risk factors, confounding, and the illusion of statistical control. Psychosom Med 2004, 66:868-875.
66. Cohen J Statistical power analysis for the behavioral sciences 1988, Lawrence Earlbaum Associates, Hillsdale, New Jersey. 2nd ed.
67. Sumathipala A What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med 2007, 69:889-900.
68. Kraemer HC, Stice E, Kazdin A, Offord D, Kupfer D How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am J Psychiatry 2001, 158:848-856.